In a cisplatin-induced AKI model, naked synthetic siRNA targeting p53 injected intravenously 4 h after IR injury reduced upregulated p53 expression, protecting both PTCs and kidney function (Molitoris et al., 2009). This evidence concerns the gene TP53 and acute kidney injury.